Predicted Trait | |
Reported Trait | Type 2 diabetes (T2D) |
Mapped Trait(s) | type 2 diabetes mellitus (MONDO_0005148) |
Score Construction | |
PGS Name | T2D_PRS_CS |
Development Method | |
Name | PRS-CS |
Parameters | a=1, b=0.5, phi=auto, MCMC iterations = 1000, burnin iterations = 500, LD reference panel = UK Biobank (EUR) |
Variants | |
Original Genome Build | hg19 |
Number of Variants | 1,108,235 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000605 |
Citation (link to publication) | Deutsch AJ et al. Diabetes Care (2023) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | |
PGS Evaluation |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST010555 Europe PMC: 32541925 |
1,114,458 individuals | European | DIAMANTE, MVP |
GWAS Catalog: GCST010556 Europe PMC: 32541925 |
56,092 individuals | African American or Afro-Caribbean | DIAMANTE, MVP |
GWAS Catalog: GCST010554 Europe PMC: 32541925 |
20,445 individuals | Hispanic or Latin American | DIAMANTE, MVP |
GWAS Catalog: GCST010553 Europe PMC: 32541925 |
216,287 individuals | East Asian, South Asian | DIAMANTE, MVP |
Europe PMC: 36653562 |
[
|
European (Finnish) |
FinnGen |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM021085 | PSS011514| African Ancestry| 7,010 individuals |
PGP000606 | Szczerbinski L et al. medRxiv (2023) |Ext.|Pre |
Reported Trait: Type 2 diabetes | OR: 1.43 [1.35, 1.52] | AUROC: 0.76 [0.74, 0.77] | — | age, sex, 10 principal components | — |
PPM021086 | PSS011516| Hispanic or Latin American Ancestry| 5,382 individuals |
PGP000606 | Szczerbinski L et al. medRxiv (2023) |Ext.|Pre |
Reported Trait: Type 2 diabetes | OR: 2.09 [1.92, 2.27] | AUROC: 0.84 [0.82, 0.86] | — | age, sex, 10 principal components | — |
PPM021087 | PSS011517| East Asian Ancestry| 663 individuals |
PGP000606 | Szczerbinski L et al. medRxiv (2023) |Ext.|Pre |
Reported Trait: Type 2 diabetes | OR: 1.8 [1.4, 2.32] | AUROC: 0.84 [0.79, 0.9] | — | age, sex, 10 principal components | — |
PPM021088 | PSS011518| European Ancestry| 22,306 individuals |
PGP000606 | Szczerbinski L et al. medRxiv (2023) |Ext.|Pre |
Reported Trait: Type 2 diabetes | OR: 2.33 [2.23, 2.43] | AUROC: 0.77 [0.76, 0.78] | — | age, sex, 10 principal components | — |
PPM021089 | PSS011519| South Asian Ancestry| 323 individuals |
PGP000606 | Szczerbinski L et al. medRxiv (2023) |Ext.|Pre |
Reported Trait: Type 2 diabetes | OR: 2.28 [1.64, 3.16] | AUROC: 0.88 [0.81, 0.95] | — | age, sex, 10 principal components | — |
PPM021090 | PSS011515| Multi-ancestry (including European)| 35,684 individuals |
PGP000606 | Szczerbinski L et al. medRxiv (2023) |Ext.|Pre |
Reported Trait: Type 2 diabetes | OR: 1.93 [1.87, 1.99] | AUROC: 0.75 [0.74, 0.75] | — | age, sex, 10 principal components | — |
PPM021084 | PSS011513| Multi-ancestry (including European)| 546 individuals |
PGP000605 | Deutsch AJ et al. Diabetes Care (2023) |
Reported Trait: Glucocorticoid-induced hyperglycemia | OR: 1.44 [1.02, 2.04] | AUROC: 0.68 | — | eGFR, glucocorticoid dose | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011513 | Manual curation of electronic medical records. Cases had no ICD code for diabetes, received a glucocorticoid dose equivalent to >= 10 mg of prednisone, and had random blood glucose >= 200 mg/dL or fasting blood glucose >= 126 mg/dL (drawn between 4:00 AM and 6:59 AM) | — | [
|
— | Asian unspecified | — | MGBB | — |
PSS011513 | Manual curation of electronic medical records. Cases had no ICD code for diabetes, received a glucocorticoid dose equivalent to >= 10 mg of prednisone, and had random blood glucose >= 200 mg/dL or fasting blood glucose >= 126 mg/dL (drawn between 4:00 AM and 6:59 AM) | — | [
|
— | African American or Afro-Caribbean | — | MGBB | — |
PSS011513 | Manual curation of electronic medical records. Cases had no ICD code for diabetes, received a glucocorticoid dose equivalent to >= 10 mg of prednisone, and had random blood glucose >= 200 mg/dL or fasting blood glucose >= 126 mg/dL (drawn between 4:00 AM and 6:59 AM) | — | [
|
— | European | — | MGBB | — |
PSS011513 | Manual curation of electronic medical records. Cases had no ICD code for diabetes, received a glucocorticoid dose equivalent to >= 10 mg of prednisone, and had random blood glucose >= 200 mg/dL or fasting blood glucose >= 126 mg/dL (drawn between 4:00 AM and 6:59 AM) | — | [
|
— | Not reported | — | MGBB | — |
PSS011514 | — | — | [
|
— | African American or Afro-Caribbean | — | AllofUs | — |
PSS011515 | — | — | [
|
— | African American or Afro-Caribbean | — | AllofUs | — |
PSS011515 | — | — | [
|
— | Hispanic or Latin American | — | AllofUs | — |
PSS011515 | — | — | [
|
— | East Asian | — | AllofUs | — |
PSS011515 | — | — | [
|
— | European | — | AllofUs | — |
PSS011515 | — | — | [
|
— | South Asian | — | AllofUs | — |
PSS011516 | — | — | [
|
— | Hispanic or Latin American | — | AllofUs | — |
PSS011517 | — | — | [
|
— | East Asian | — | AllofUs | — |
PSS011518 | — | — | [
|
— | European | — | AllofUs | — |
PSS011519 | — | — | [
|
— | South Asian | — | AllofUs | — |